In 2011, a majority shareholding in Medicover was donated by Jonas af Jochnick to the newly established charitable Foundation: Jonas and Christina af Jochnick Foundation.
Medicover's competition in Central and Eastern Europe originally consisted of small local companies, mainly physician owned and controlled. Now, many of those companies have been bought up by Private Equity investors. Their interest in the region is of course driven by the strong growth outlook, and also to some extent the example of success evidenced by Medicover.
The Private Equity owners by definition have a much shorter time horizon than Medicover's shareholders. It leads to periods of intense and often price based competition as these businesses seek to gain share and grow volumes. However, given that much of the asset and capability development required for success and leadership in healthcare is by nature long term, Medicover considers its long term focus a competitive advantage.